Gabrail Cancer Center Research LLC is a clinical research site located in Canton, Ohio, United States 44718.
Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.
Gabrail Cancer Center Research LLC has participated in 5 clinical trials with 3 currently active.
Therapeutic areas: Relapsed/Refractory Diffuse Large B-cell Lymphoma, Locally Advanced Unresectable or Metastatic Solid Tumors Including Esophageal Cancer, Esophageal Adenocarcinoma.
Sponsors: Karyopharm Therapeutics Inc, Taiho Oncology, Inc., NovaRx Corporation.
Trust Score: 73/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Gabrail Cancer Center Research LLC has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Gabrail Cancer Center Research LLC has 5 clinical trials on record, with 3 currently active. Their work covers Relapsed/Refractory Diffuse Large B-cell Lymphoma, Locally Advanced Unresectable or Metastatic Solid Tumors Including Esophageal Cancer, Esophageal Adenocarcinoma.
Gabrail Cancer Center Research LLC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.